{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:44:05Z","timestamp":1790441045925,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.adro.2019.06.001","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T12:11:33Z","timestamp":1560341493000},"page":"683-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?"],"prefix":"10.1016","volume":"4","author":[{"given":"Mark T.","family":"Corkum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varagur","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2019.06.001_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1200\/JCO.2015.63.9898","article-title":"Importance of radiation oncologist experience among patients with head-and-neck cancer treated with intensity-modulated radiation therapy","volume":"34","author":"Boero","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib3","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1200\/JCO.2014.56.5218","article-title":"Institutional clinical trial accrual volume and survival of patients with head and neck cancer","volume":"33","author":"Wuthrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.radonc.2012.02.010","article-title":"Heterogeneity in head and neck IMRT target design and clinical practice","volume":"103","author":"Hong","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.semradonc.2005.01.005","article-title":"Target definition in prostate, head, and neck","volume":"15","author":"Rasch","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","article-title":"Delineation of the primary tumour clinical target volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG oncolog","volume":"126","author":"Gr\u00e9goire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijrobp.2010.09.038","article-title":"Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: Implications for the management of head-and-neck cancers","volume":"82","author":"Campbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.06.001_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0002-9610(97)00282-1","article-title":"Clinicopathological analysis of local spread of carcinoma of the tongue","volume":"175","author":"Yuen","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.adro.2019.06.001_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.canrad.2014.04.006","article-title":"Microscopic extensions of head and neck squamous cell carcinomas: Impact for clinical target volume definition","volume":"18","author":"Fleury","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2019.06.001_bib11","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2017.06.003","article-title":"European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer","volume":"124","author":"De Ruysscher","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0360-3016(00)00750-1","article-title":"Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning","volume":"48","author":"Giraud","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2019.06.001_bib14","series-title":"Radiotherapy for head and neck cancers. Indications and techniques","author":"Garden","year":"2018"},{"key":"10.1016\/j.adro.2019.06.001_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jamaoncol.2016.4510","article-title":"Effect of standard radiotherapy with cisplatin vs accelerated radiotherapy with panitumumab in locoregionally advanced squamous cell head and neck carcinoma","volume":"3","author":"Siu","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib16","unstructured":"ClinicalTrials.gov. Radiation therapy with cisplatin or cetuximab in treating patients with oropharyngeal cancer (RTOG 1016). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01302834. Accessed February 28, 2019."},{"key":"10.1016\/j.adro.2019.06.001_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2407-13-133","article-title":"Early-stage squamous cell carcinoma of the oropharynx: Radiotherapy vs. Trans-Oral Robotic Surgery (ORATOR) \u2013 study protocol for a randomized phase II trial","volume":"13","author":"Nichols","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2019.06.001_bib18","unstructured":"ClinicalTrials.gov. Randomized phase II trial of transoral endoscopic head and neck surgery followed by risk-based IMRT and weekly cisplatin versus IMRT and weekly cisplatin for HPV negative oropharynx cancer. Available at: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01953952. Accessed February 28, 2019."},{"key":"10.1016\/j.adro.2019.06.001_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/jso.21014","article-title":"Intensity-modulated radiation therapy","volume":"97","author":"Lee","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2019.06.001_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2018.06.032","article-title":"The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)","volume":"130","author":"Navran","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109419300624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109419300624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:36:40Z","timestamp":1762529800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109419300624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2452109419300624"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2019.06.001","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2019.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}